Artificial AGCs
can serve as noncollapsible scaffolds, whereby regenerating nerve fibers can extend toward their target without neuroma formation. 72 Clinically, AGCs are relegated to short gaps in small sensory nerves, such as the digital nerve of the hand. However, in several case reports, AGCs have been used to repair larger, mixed motor-sensory nerves of the arm. 46, 50, 51 It has been demonstrated that each animal species has its own upper limit for the maximum nerve gap distance that can be effectively bridged by an empty acellular conduit. 47, 48 In rats, conduits alone fail to support regeneration in sciatic nerve gaps greater than 13 mm. 23, 47, 80 In nonhuman primates, this critical gap length is 2 cm in the median nerve 37, 53 and 3 cm in the ulnar nerve. 31 The same principle applies to humans with peripheral nerve injuries in a clinical setting. Nerve injuries with long segmental defects in humans pose a similar challenge in which gap lengths of more than 6 cm have extremely poor clinical outcomes. 36, 66 Several studies have focused on alternative methods that circumvent the problem of repairing critical gap length lesions by using cadaveric nerves (allografts) 57 or artificial conduits.
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Clinically viable alternatives must be advanced to improve functional outcomes. We have developed a cellular-based treatment regimen that uses synthetic conduits in conjunction with biological factors from SCs to repair segmental loss caused by peripheral nerve injury. 28, 33 It has been well documented in the literature that SCs secrete neurotrophic factors that promote axonal survival and growth, besides their main role in myelination. 10, 34, 35, 43, 64 Such beneficial characteristics make these cells an excellent candidate for forming a biological scaffold that will make the environment inside the channel more hospitable for axons that are entering it from the proximal stump. 65 We have demonstrated that SCs isolated for human peripheral nerve can be propagated using cell culture techniques and can survive, remyelinate, and enhance axonal regeneration in immune-deficient rodents after sciatic nerve injury. [41] [42] [43] [44] Thus many of the critical elements for human autologous SC-based cellular therapy for nerve injury have been demonstrated. In the present study, we examined whether the addition of autologous SCs to a commercially available AGC enhances axonal regeneration in restoring long peripheral nerve gaps in adult male Fischer rats.
Methods

NeuraGen Nerve Guide
The NeuraGen nerve guide (Integra LifeSciences Corp.) is manufactured from bovine Type I collagen as an absorbable implant for the repair of peripheral nerves with discontinuities. It is a semipermeable tube that, when hydrated, is easy to handle, soft, pliable, nonfriable, and porous. It is approved by the FDA and is commercially available. The NeuraGen tube used in the present study (PNG-130) had a 1.5-mm internal diameter × 15-mm length.
Preparation of SCs for Grafting
Schwann cells were obtained from the sciatic nerves of adult female Fischer rats (Harlan Bioproducts for Science), as described previously. 41, 58 Two weeks later, after the outward migration of fibroblasts, the explants were transferred to new dishes where they were enzymatically dissociated and replated in DMEM/10% FBS supplemented with 3 mitogens: bovine pituitary extract (2 mg/ml, Invitrogen Corp.), forskolin (0.8 mg/ml, Sigma), and heregulin (2.5 nM, Genentech). 55 Cells were grown to confluency and passaged to new dishes 3 times. Their purity for grafting, ensured using a method described earlier, 70 was found to be 95%-98%. Blood was collected from a donor male Fischer rat and processed in a centrifuge for 10 minutes at 3200 rpm. Serum was collected and used to prepare the grafted SCs in a concentration of 200,000 cells/ml.
Lentiviral Vectors
Lentiviral Vector Preparation. Vector preparation was performed as previously described. 22 Briefly, the gene encoding enhanced GFP was subcloned into a lentiviral vector plasmid. This plasmid contained the cytomegalovirus promoter to drive transgene expression and the Woodchuck posttranscriptional regulatory element to enhance mRNA transport. Plasmid transfection and viral harvesting were conducted in cultured 293T cells. Virus was concentrated by ultracentrifugation at 20,000g and resuspended in phosphate-buffered saline. Thereafter, the viral vectors were titrated for transducing units on 293T cells by using an enzyme-linked immunosorbent assay (Perkin Elmer Inc.) for quantifying p24 core protein concentrations, according to the manufacturer's instructions. Purified viral vector stocks were stored at -80°C until SC transfection.
Lentiviral Vector Transduction of SCs to Express GFP.
Virus concentrated in phosphate-buffered saline was used to infect SCs. Cultures were infected by adding a predetermined volume of concentrated virus in DMEM with 10% FBS and mitogens. A multiplicity of infection of 50 was used in all cultures to ensure high transduction efficiency (95%-98%) with an absence of toxicity.
Experimental Design
Eighty adult male Fischer rats (Charles River Laboratories International Inc.) and 10 male Lewis rats (Harlan Bioproducts for Science Inc.), with a mean weight of 450 g, were used for this study. All animals were housed according to the NIH guidelines for the care and use of laboratory animals and were given ad libitum access to food and water. The Institutional Animal Care and Use Committee of the University of Miami approved all animal procedures. Fischer rats were randomly divided into 4 experimental groups (A-D) and 1 control group consisting of naïve, uninjured (E) animals (16 rats per group). NeuraGen tubes filled with either unlabeled or GFP-labeled SCs were implanted in rats in Groups A and B, respectively. Animals in Group C received NeuraGen tubes filled with serum only as a negative control, and animals in Group D had sciatic nerve reversed autografts. Survival times for each group were 4 (8 rats) and 16 (8 rats) weeks postsurgery. The Lewis strain was used to test previously reported observations of its decreased tendency to automutilation behavior following peripheral nerve transections.
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All 10 Lewis rats were assigned to Group F and were submitted to sciatic nerve reversed autografts.
Operative Procedure
Rats were anesthetized with 1%-2% isoflurane in a mixture of 70% nitrous oxide and 30% oxygen. An adequate level of anesthesia was determined by monitoring the corneal reflex and hindlimb withdrawal to painful stimuli. Prior to surgery, the right leg of each animal was shaved. Under aseptic conditions and with the rats under anesthesia, an incision was made over the right iliac crest along the anterior medial aspect of the thigh after retracting the gluteus maximus muscle. The sciatic nerve was exposed by reflecting the biceps femoris muscle from its origin and was mobilized from the ischial tuberosity to the tibioperoneal bifurcation by gentle dissecting of the overlying connective tissue sheets. Once the nerve was freed from surrounding connective tissue, it was sectioned 4 mm proximal to the tibioperoneal bifurcation, and a 13-mm-long piece of nerve was resected and discarded (or reversed for autograft surgeries) to make a 15-mm gap. The 2-mm difference allowed tension-free nerve repair. The gap between the stumps of the sectioned nerve ends was replaced with a NeuraGen tube having an internal diameter of 1.5 mm and a length of 15 mm. Both nerve stumps were inserted 1 mm into the openings of either end of the tube so that they were separated by a 13-mm gap. The tube was anchored to the sciatic nerve stumps using a 9-0 monofilament nylon suture (Ethicon Inc.). In the experimental Groups A and B, the tubes were filled with rat SCs (either unlabeled or GFP-labeled) at a concentration of 2 × 10 5 cells/ml. In the negative control Group C, the tubes contained rat serum only, without cells. To ensure that no leakage occurred, both ends of the NeuraGen tube were sealed with fibrin sealant (Tisseel VH, Baxter Healthcare Corp.). In Groups D and F, a 13-mm-long piece of right sciatic nerve was removed and rotated to align the distal end of the nerve segment with the proximal nerve stump and the proximal end of the nerve piece with the distal nerve stump. The reversed nerve autograft was secured in place using 2-3 epineurial stitches using a 9-0 monofilament nylon suture. The wound was then closed in layers. During surgery, rats were kept on a heating pad to maintain body temperature at 37 ± 0.5°C.
Behavioral Testing
Footprint analysis was performed on a weekly basis in the 4-and 16-week animal groups by using a procedure modified from de Medinaceli et al., as described by Varejão et al. 17, 73 Each animal's hind paws were inked to record footprints on paper that covered a narrow runway 1 m long by 7 cm wide. A series of at least 8 sequential steps were used to determine the mean values for each measurement of print length (PL), toe spread (TS), and intermediary toe spread (ITS). The PL was determined by measuring the core-to-core distance of the heel pad to the third toe. The TS was defined as the distance between the first and fifth toes, and the ITS was measured between the second and fourth toes. The sciatic functional index (SFI) was calculated as follows: (-38.3 × PL factor) + (109.5 × TS factor) + (13.3 × ITS factor) -8.8. 6 Each of the factors was calculated by subtracting the value measured for a naïve animal (normal factor) from the value measured for an experimental animal (PL, TS, or ITS), divided by the normal factor. For example, the PL factor = (experimental PL -normal PL)/normal PL.
Autotomy Scores
Autophagia was assessed on a weekly basis, and a score based on the autotomy modified scoring scale by Wall et al. 77 was assigned to all animals. The scale ranges from 0 through 11. The first point is given for the injury of 2 or more nails, and each additional point is given for the injury of each distal half digit.
Histological Analysis
All rats were transcardially perfused at 4 or 16 weeks after transplant surgery by using 200 ml of 0.9% NaCl solution, followed by 500 ml of ice-cold 4% paraformaldehyde (pH 7.4). Tissue samples were postfixed overnight in the same fixative at 4°C and then transferred to phosphate-buffered 30% sucrose for at least 48 hours at 4°C for cryoprotection. Samples designated for immunohistochemical analysis were embedded in M-1 embedding matrix (Thermo Electron Corp.) and cut into serial consecutive sections using a cryostat freezing microtome (CM1900, Leica Microsystems). All sections were put on glass slides coated with poly-l-lysine and kept at -20°C until further processing. For semithin light microscopy analysis, a 15-mm-long segment of either the reversed autograft or the NeuraGen tube with 1 mm of the proximal and distal sciatic nerve stumps attached at the ends was divided into three 2-mm-long pieces (namely proximal, midpoint, and distal). Each of these fragments was rinsed in 0.15 M of phosphate buffer before immersion in 1% osmium tetroxide in 0.1 M of phosphate buffer for 2-16 hours. The tissue was rinsed again in phosphate buffer, dehydrated in graded ethanol, ending in propylene oxide, and embedded in Epon-Araldite resin (Electron Microscopy Sciences). One-micrometer plastic sections were cut in cross-sections and stained with a 1% toluidine blue-1% methylene blue-1% sodium borate solution.
Immunohistochemical Procedures
Sections were stained with monoclonal or polyclonal antibodies or both. Frozen sections were thawed, air-dried, washed once with 1× TBS for 5 minutes, and treated with 1× TBS combined with 10% normal goat serum and 0.5% Triton X-100 at room temperature for 2 hours. Overnight incubation with primary antibody was performed in humidified boxes at room temperature. The primary antibodies were diluted in 1× TBS with 1% normal goat serum. The monoclonal antibodies used were anti-neurofilament high (1:500, Chemicon), anti-myelin basic protein (SMI-94, 1:500, Covance Research Products), anti-glial fibrillary acidic protein (SMI-22R, 1:500, Covance Research Products), and anti-macrophages/monocytes (ED-1, 1:200, Millipore). The polyclonal antibodies used were anti-S100 protein (1:500, Dako) and anti-GFP (1:500, Millipore). The following morning, sections were rinsed in 1× TBS 3 times for 30 minutes total and incubated at room temperature for 1 hour with secondary fluorescent-conjugated antibody. The secondary antibodies used were Alexa 488/594-conjugated goat anti-rabbit (1:200, Molecular Probes), Alexa 488/594-conjugated goat anti-mouse (1:200, Molecular Probes), or Alexa 488-conjugated goat anti-chicken (1:200, Millipore). We used DAPI as a nucleic acid stain (1:1000, Molecular Probes). After washing the sections 3 times with 1× TBS, we air-dried them, added VectaShield mounting medium (Vector Laboratories), placed a coverslip, and examined the sections under an Olympus FluoView FV1000 confocal laser scanning microscope (Olympus America Inc.).
Statistical Analysis
One-way ANOVA followed by the Bonferroni post hoc test was used to compare resultant axon counts and behavioral analysis. Significant temporal differences in autotomy levels (pain assessment) between groups or differences in retrogradely traced neurons in different neuroanatomical regions of the spinal cord between groups were determined using a 2-way ANOVA with a Tukey honestly significant difference post hoc test. A mixed factorial (repeated measures) ANOVA followed by the Tukey-Kramer test was used for comparison of weekly functional recovery patterns after the different treatment modalities. Differences were accepted to be statistically significant at p < 0.05, p < 0.01, and p < 0.001, as compared with naïve controls or reversed autografts. All errors are expressed as standard errors of the means. Effect size was calculated using the Cohen d statistic to display the magnitude of a difference that can be compared across studies as well as with objective guidelines. These guidelines were 0.20 (for small effects), 0.50 (for medium effects), and 0.80 (for large effects).
Results
Survival of Transplanted GFP-Labeled SCs
Green fluorescent protein expression within the pool of transfected SCs was 97% (Fig. 1) . Autologous SCs mixed with pooled rat blood serum were used to fill a NeuraGen nerve guide (15 mm) to repair a 13-mm gap in the rat right sciatic nerve. Green fluorescent protein fluorescence activity was distributed along the length of the NeuraGen nerve guide and was detected up to 16 weeks after surgical repair, suggesting survival of the transplanted SCs (Fig. 2A) . Migration of endogenous SCs from the nerve stumps into the NeuraGen nerve guide was suggested by immunostaining with S100 given that the number of S100-positive SCs significantly exceeded the number of GFP-labeled SCs (Fig. 2B and C ). There were ED1-positive cells within the NeuraGen tube containing SCs at 4 weeks, but a decreased inflammatory response was seen at 16 weeks (Fig. 3) . Neurofilaments, a major component of the axonal cytoplasm, were also seen in the lumen of the nerve guide closely associated with the GFP-labeled SCs 16 weeks posttransplantation (Fig. 4) .
Number of Myelinated Axons
The number of myelinated axons labeled with toluidine blue stain on semithin sections within the NeuraGen nerve guide was counted at 4 and 16 weeks postsurgery using the stereological software StereoInvestigator (MBF Bioscience) and computer-assisted microscopy (Figs. 5 and 6). At 4 weeks postsurgery (Figs. 5 and 7 upper), there were more myelinated axons in the proximal area of the SC-filled tube (7713 ± 971.69) than in the proximal area of the reversed autograft (5896 ± 189.84), but considerably fewer myelinated axons were found at the midpoint (1467 ± 370.86) and distal (687 ± 460.18) areas of the SC-filled tube. The number of myelinated axons showed a progressive decline from the proximal to the middle (4849 ± 283.06) and distal (4482 ± 135.78) points in the reversed autograft group. When the NeuraGen guide was filled with rat serum only, no axonal regeneration occurred at 4 weeks.
At 16 weeks postsurgery (Figs. 6 and 7 lower), the number of myelinated axons in the SC-filled NeuraGen group was similar in all 3 cross-sectional levels (proximal 7640 ± 768, midpoint 4756 ± 240.16, distal 5126 ± 279.47), which indicates that axons grew into the NeuraGen guide and elongated all the way toward the distal nerve stump. In the reversed autograft group, the number of myelinated axons at the distal level (9838 ± 623.13) was slightly higher than the number at the midpoint (8528 ± 939.67) but similar to the count at the proximal level (10714 ± 178.83). The NeuraGen + SCs as well as the reversed autograft groups had a significantly greater number of myelinated axons than the serum-only group, at all 3 levels. In a naïve animal, the total number of myelinated axons was 7538 ± 178.83 (data not shown).
Axonal Area
At 4 weeks postsurgery (Fig. 8 upper) , axonal areas for the NeuraGen + SCs group were 6.591 ± 0.589, 3.817 ± 1.094, and 0.886 ± 0.886 mm 2 for proximal, midpoint, and distal levels, respectively. For the reversed autograft group, the axonal areas were similar in all 3 cross-sectional points (proximal 5.574 ± 0.534, midpoint 5.208 ± ). There was no axonal area to be measured in the tubes filled with rat serum only at 4 weeks. Overall, the axonal areas measured in the 16-week animals with SCs added to the NeuraGen guide were larger than the areas measured at 4 weeks (Fig. 8  lower) . Proximally, the mean area was 9.91 ± 1.380; at the midpoint, 9.43 ± 0.900; and distally, 8.78 ± 0.400 mm 2 . Despite the low number of myelinated axons counted in the NeuraGen tube filled with rat serum only, the few axons that did grow into the nerve guide had mean areas smaller (proximal 7.03 ± 0.75, midpoint 9.32 ± 0.28, distal 7.81 ± 0.65 mm 2 ) than the NeuraGen + SCs and reversed autograft groups. The reversed autograft group had the largest axonal areas of all 3 experimental groups (proximal 11.83 ± 1.76, midpoint 13.3 ± 1.53, distal 10.3 ± 0.68 mm 2 ). The control axonal area measured in naïve animals was 52.52 + 0.64 mm 2 at all 3 levels (data not shown).
Walking Track Analysis and SFI Scores
Three different footprint measurements were obtained by testing the animals weekly using walking track analysis. At the end of 4 weeks, the PL, TS, and ITS values for the NeuraGen + SCs group were 34.616 ± 0.65, 17.94 ± 0.31, and 12.67 ± 0.45, respectively. In the serum-only group, the TS and the ITS decreased to 15.75 ± 0.75 and 11.50 ± 0.17, whereas the PL increased to 37.22 ± 0.64 compared with the NeuraGen + SCs group. The animals subjected to a reversed autograft showed the lowest values for TS and ITS (9.5 ± 0.56 and 6.79 ± 0.44, respectively) and the highest value for PL (38.4 ± 0.46; Fig. 9 upper) . The trend was similar at the 16-week end point, with results from the NeuraGen + SCs group (TS 18.28 ± 0.269, At both 4 and 16 weeks, the SFI scores for the NeuraGen + SCs group (-12.8 and -5.23, respectively) were the closest to 0, which is the score given to a naïve animal. In contrast, animals in the reversed autograft group had the lowest scores regardless of the time point (-74.31 at 4 weeks and -63.46 at 16 weeks). An SFI of -100 indicates an animal with a transected nerve injury. The SFI for the serum-only group at 4 weeks was -30.34, and at 16 weeks, -27.83.
Autotomy Scores
There was a significant reduction in autotomy scores when comparing SC-seeded nerve guides (0.25 ± 0.25) with reversed autografts (2.875 ± 0.92) up to 16 weeks posttransplantation. Animals in the serum-only group had intermediary autotomy scores (1.125 ± 0.50). Lewis rats with reversed sciatic nerve grafts exhibited minimal to no autotomy behavior (Fig. 10) .
Discussion
In the present study, we used an FDA-approved, absorbable bovine Type I collagen AGC. The fibrillar structure of the collagen is maintained throughout manufacture, permitting construction of a tubular matrix that has excellent mechanical strength and defined permeability. 3, 30, 45 The level of functional recovery achieved with the NeuraGen conduit has been equivalent to direct suture repair of short-segment defects in several experiments in both rats and primates. 4 The use of NeuraGen nerve guides in combination with cultured autologous SCs could expand the clinical potential of the nerve guide, permitting the repair of a larger array of peripheral nerve injuries, even those with a lengthy gap. 2 In experimental peripheral nerve repair with conventional AGCs, there is a definite length limit or "critical" gap length between the proximal and distal stumps of a cut nerve in which nerve regeneration will not occur. The distance is species specific. In the rat sciatic nerve, this critical distance measures > 10 mm, and in the primate ulnar nerve it is > 3 cm.
23,31,47-49,52,81-83 Critical distances can be overcome by adding exogenous growth factors and/or tissues to the tube environment. In the rat, a 13-mm gap can be successfully bridged using silicone chambers only when exogenous fibrin matrix precursors or a small segment of degenerated peripheral nerve is added to the conduit. 23, 40, 47, 48, [81] [82] [83] More specifically, some authors have demonstrated no evidence of regeneration within an empty or saline-filled 15-mm silicone tube (13-mm nerve gap) at 16 weeks, but the addition of a short, interposed, 2-mm nerve segment resulted in significant regeneration similar to that of an autograft. In the monkey, a 3-cm gap can be repaired with a bioabsorbable polyglycolic acid tube. 18 Research in primates support the clinical use of NeuraGen tubes for gaps up to 50 mm; thus, these tubes are commonly used to repair gaps < 3 cm in humans. 3, 4, 37 In our experimental paradigm, the NeuraGen nerve guide was used to repair what is considered a long sciatic nerve defect in rats (13 mm). This gap represents a large segmental defect compared with the total length of the rat sciatic nerve. The distance from the sciatic notch to the ankle of the sciatic nerve in a large 8-month-old rat measures 25 mm; thus, the gap defect of 13 mm represents over half the distance of the entire nerve. In our experiments we used large male Fischer rats (± 450 g) with an average age of 8 months in part because the smallest NeuraGen tube manufactured has an internal diameter of 1.5 mm. An 8-month-old rat might be considered "aged," and there is evidence that older rats are not as capable of spontaneous regeneration as their younger counterparts.
14 In the current study, we performed a negative control (tube filled with serum only) in animals of a similar age and species to assess spontaneous regeneration potential within the collagen tube. While a critical gap distance for which spontaneous regeneration will not occur has been established, nerve diameter is probably also an important determinant. 57 Large-diameter fibers are less likely to spontaneously generate into an AGC-presumably because of a dilution of neurotrophic factors within the larger channel volume. 57 It has been shown that SCs are the principal support cells throughout the PNS and have a remarkable capacity to promote nerve fiber regeneration in both the PNS and the CNS when transplanted. 5, 16, 28, 61, 84, 85 Schwann cells have also been shown to secrete specific neurotrophic factors that promote neuron survival and differentiation.
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The use of cell culture techniques to obtain an abundant source of autologous graft material from a small biopsy is an approach that has already met with clinical success in providing human epidermal cells to cover extensive burns, for example. 25, 26 Green fluorescent protein expression confirmed that the transplanted SCs survived inside the collagen nerve guide for up to 16 weeks. There was a gradient in the distribution of GFP-labeled SCs throughout the conduit, with the maximum number of SCs seen within the central portion of the channel. At both time points, there ) of myelinated axons at 3 different levels at 4 weeks after surgery. Since there were no myelinated axons inside the tube filled with serum only, no areas were measured for this group. There was no significant difference in axonal areas between the tube + SCs and the reversed autograft groups at the proximal and midpoint levels. However, the cross-sectional areas of axons measured distally in the reversed autograft group were larger than in the tube + SCs group (p < 0.01). Lower: Bar graphs of the mean cross-sectional areas of myelinated axons measured at 3 different levels at 16 weeks postsurgery. There was no significant difference in axonal areas among the experimental groups in any of the 3 levels, except between the serum-only and reversed autograft groups at the distal level (p < 0.05). On average, the cross-sectional area of myelinated axons in an uninjured (naïve) sciatic nerve was 5 times larger than the areas measured in any of the experimental groups (data not shown). Error bars represent the standard errors of the means. was invasion from host-derived SCs, which outnumbered the transplanted GFP-labeled SCs, as revealed by S100 labeling.
Histological Analysis of Regenerated Cables Within Treatment Groups
The number of myelinated axons and their cross-sectional areas were measured at 3 different levels (proximal, midpoint, and distal) of the NeuraGen tubes and reversed autografts in all animal groups. The serum-only group showed no significant axonal regeneration at 4 weeks. Within the SC group, myelinated axons were present over the length of the tube, but the reversed autograft contained more myelinated axons at the middle and distal levels of the regenerated cable. At 16 weeks in the tube + SCs group, there was a significantly greater number of myelinated axons at the proximal level, as compared with the middle and distal levels. Axon counts at the middle and distal points for this group were not statistically different and represented approximately half of the total number of myelinated axons in a naïve animal. The fact that myelinated axons were present throughout the entire length of the nerve guide suggests that at the end of 16 weeks, axons regenerated all the way into the distal nerve stump, beyond the SC-filled collagen conduit. The myelinated axon counts in animals that received SCs were significantly higher at all 3 levels than the counts in the serum-only group. Thus, the nerve guide filled only with serum did not support axonal regeneration as well as the SC-seeded conduit even at 16 weeks. 23, 39, 48 For the 16-week reversed autograft group, slightly more myelinated axons were counted at the distal level than at the midpoint level. Moreover, the total In the tube + SCs group, all 3 parameters returned to values comparable with those in naïve animals, suggesting that the addition of SCs to the collagen nerve guide might have a positive effect on the functional output of hindlimb muscles. In the reversed autograft and serum-only groups, the TS and ITS were significantly reduced compared with those in the naïve group (p < 0.01). Error bars represent the standard errors of the means. Fig. 10 . Autotomy scores were assessed weekly for a period of 16 weeks. Graph illustrating values up to Week 6, since scores reached a plateau and stayed the same for the remainder of the time. The reversed autograft group showed a significant increase in autotomy as compared with the tube + SCs (p < 0.001) and serum-only (p < 0.01) groups. However, when animals from a different rat strain (Lewis) were submitted to sciatic nerve reversed autografts, no autophagia was observed. Data represent the means ± standard errors of the means at each time point.
number of myelinated axons at all 3 levels of the reversed autograft group was higher than the number in the tube + SCs group as well as naïve animals. The latter may be attributable to sprouting of the regenerating nerve fibers. 1, 29, 62 There was a wide distribution of area measurements among the 4-week groups. Interestingly, the axonal area measured at the proximal level in the tube + SCs group was almost twice as large as the area measured at the midpoint level. At the distal level, the axonal area decreased by approximately 87% in relation to measurements taken at the proximal level. This finding suggests the presence of immature axonal profiles distally within the nerve guide at the 4-week time point. The serum-only group did not support axonal regeneration; therefore, no significant measurements were recorded for the axonal area in this group.
Results for the group of animals with the longest survival time showed a significant benefit in adding SCs to the NeuraGen tube in terms of the number of myelinated axons that grew inside the graft. In contrast to the progressive decline in axonal areas measured along the length of the collagen nerve guide seeded with SCs in the 4-week animals, the average axonal area for the 16-week SC group was similar at all 3 cross-sectional levels. The reversed autograft group had the largest axonal areas as compared with areas in either of the NeuraGen groups with or without SCs. In all of the 16-week experimental groups, the axonal cross-sectional area was on average more than 80% smaller than that in the naïve group. It has been well documented in the literature that one of the main characteristics of regenerating axons is their small caliber. 38, 71, 75, 76 One could further speculate that thinly myelinated axons may be less capable of forming functional neuromuscular junctions at the endplate and thus of successfully reinnervating their muscle target. The inability to reach their target could also be contributing to the small caliber of regenerating axons, since they rely in great part on the trophic support provided by the reinnervated muscle as well as the neurotrophic factors that are released by other cells in their environment, such as the SCs. 7, 11, 27, 56 
Walking Track Analysis, SFI, and Autotomy Scores
The walking track analysis was one of the tests used to assess hindlimb functional recovery. 73 As argued by Reynolds et al., 63 there is a direct correlation between the footprint measurements obtained with walking track analysis and the functional output from individual hindlimb muscles. Three parameters were evaluated: PL, TS, and ITS. The maximal distance was measured for each of these 3 values. It has been shown that rats with specific nerve injuries, such as the one used in our experimental paradigm, show distinctive changes in their gait. For example, in a complete sciatic nerve transection, the PL increases, whereas the TS and ITS decrease. 6 In our study, this observation held true for 2 of the experimental groups, namely the reversed autograft and serum-only groups at both 4 and 16 weeks after surgery. However, the addition of SCs to the NeuraGen nerve guide returned, for animals at both end points, all 3 measurements to values that were not significantly different from those in the naïve group. The SFI was calculated for each group using the formula with PL, TS, and ITS values, as described by Bain et al. 6 An SFI of 0 is normal and an index of -100 indicates total hindlimb impairment. At both 4 and 16 weeks postsurgery, the reversed autograft animals had the lowest SFI scores (-74.31 and -63.46 , respectively) among all the experimental groups. These poor scores do not positively correlate with all the other results obtained for the reversed autograft animals at either time point. This disparity in the data could be an indication of the inadequacy of walking track analysis and the SFI in the evaluation of the functional recovery of animals subjected to a complete transection injury. It has been suggested that the walking track test is more suitable for the assessment of nerve crush injuries. 67 It is also important to point out that autotomy scores must be considered when interpreting footprint measurements. In the reversed autograft group, high autotomy levels were seen at 4 weeks, but were even higher at 16 weeks. This behavior, typically observed in rats with peripheral nerve injuries, is a detriment in performing the walking track test. 74 Animals with chewed toes produce footprints that cannot be analyzed properly; thus, the data collected are unreliable. 67 To circumvent this potential problem, Lewis rats could be used as an alternative for future walking track studies, since it has been suggested that this strain is less prone to autophagia than are Fischer rats. 12, 21, 30, 39 Our laboratory has performed reversed autografts in male Lewis rats by following the same protocol applied in the current study, with 4-and 16-week survival times. The Lewis rats displayed little to no autotomy behavior.
There may be a correlation between autotomy behavior and pain. While the reversed autograft group had the most abundant regeneration, as measured by myelinated axon counts and larger axonal profiles, they also had the highest autotomy scores. One possible explanation is that the guidance channel provides a scaffold for more directional growth and/or is less permissive for the growth of pain fibers as compared with an autograft. Future experiments will focus on defining the extent of nociceptive growth into channel versus nerve autograft repairs.
Conclusions
In earlier studies, 28 we demonstrated that one can create a "simple" artificial peripheral nerve by placing SCs within a polyacrylonitrile/polyvinylchloride tube to promote the regeneration of axons across a small nerve gap in primates and immune-deficient rodents (human SCs).
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The current clinically viable experimental paradigm of focusing on long gaps within the PNS has not been previously proposed. The experimental model was planned out in a way that would make implementation toward clinical testing relatively rapid and seamless, as we used FDA-approved nerve tubes and autologous SCs and serum. While novelty and innovation are always desirable goals for any new research project, one of our primary objectives in this study was to take the best strategies in nerve repair, prove that they are effective by using multiple histological and functional end points, and tailor the repair strategy for use in humans without the need for advanced testing or FDA approval of multiple new materials.
In addition to studying novel types of AGCs, other groups of authors are testing various types of cells that can be isolated, expanded, and differentiated into SCs and combined with nerve guides. Alternative sources of SCs have been investigated, such as SCs derived from BMSCs and SKPs. 19, 78, 86 In 2007, Chen and colleagues showed that BMSCs are also capable of differentiating into fibroblastlike cells in vitro and that these cells secrete neurotrophic factors when transplanted into a tube to repair a 15-mm gap in the rat sciatic nerve. 13 This finding supports previous observations that BMSCs can be used as a viable cellular alternative for the repair of peripheral nerve injuries, given that they have the ability to differentiate into SCs as well as fibroblast-like cells. Skin-derived precursors are also a class of cells that can be a promising source of functional SCs. Briefly, SKPs are neural crest-related precursors found in, but not restricted to, the neonatal and adult skin of rodents and humans. Since SKPs are skin derived, they are easily accessible and represent a renewable source of SCs. McKenzie and colleagues have shown that SKPs differentiate into SCs, which in turn proliferate and myelinate regenerating axons when transplanted in vivo into the crushed sciatic nerve of rats. 54 Moreover, SKP-derived SCs have also been shown to survive and promote axonal growth when transplanted into the contused rat spinal cord. 9 Besides SCs, embryonic stem cells are also vastly used in transplantation strategies. However, therapies that rely on the use of embryonic stem cells have always been met with ethical questions, which have led several groups to focus on developing new methods of obtaining pluripotent cells that express the same cell marker genes while retaining morphological characteristics identical to those of embryonic stem cells. One example is the induction of pluripotent stem cells by reprogramming adult somatic cells, as first described by Takahashi and Yamanaka in 2006. 69 Authors of ongoing research are conducting comparative gene expression analysis of embryonic stem cells and induction of pluripotent stem cells and testing the safety of such modified cells. The development of quality control assays will also be needed before the induction of pluripotent stem cells can be considered for future clinical applications. 59 The current investigation established a clinically relevant small-animal model whereby the potential of autologous SCs to promote peripheral nerve regeneration within the environment of an AGC extending across a long nerve gap could be reliably assessed. In their current form, AGCs appear to have limited clinical applicability, and thus there is the potential for enhancing regenerative responses with the use of additional substrates. This study will significantly contribute to the nascent field of "AGC engineering" aimed at maximizing axonal growth through modulation of the microenvironment within the AGC. Establishing a novel system not only to investigate cultured SCs in conduits but also to develop a reproducible paradigm will allow future investigations along this line. This novel but simple artificial neural prosthesis for peripheral nerve repair couples SCs isolated in cell culture with biomaterials and surgery for peripheral nerve repair. The experiments outlined in this article are goal oriented and were performed to address some of the final and critical steps that will bring autologous SC transplantation to humans. 
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